TYBR Health Analysis
What is TYBR Health?
TYBR Health develops the B3 GEL System, a flowable ECM-based bio-gel barrier for tendon and ligament repair. The company says the gel creates a protective environment around healing tissue and supports post-operative tendon mobility. Its website references validation work with the University of Virginia and physician use in surgical settings.
Location
2450 Holcombe Blvd, Houston, Texas 77021, United States
Employees
1-10
Founded
2020
Revenue
$0-5M
Company Stage
Seed
YC Batch
W22
Product Features & Capabilities
- Healing tendon and ligament protection, Hydrogel for scar prevention, Internal organ scar prevention, Extracellular matrix solution for adhesion prevention.
Who are the founders of TYBR Health
TK
Tim Keane
CEO
AS
Alex Smith
CTO
Market Focus
TYBR Health primarily focuses on the healthcare industry, specifically in the development of innovative biomaterial therapies for the protection and healing of tendons and ligaments during recovery after surgery.
Investors
- Asymmetry Ventures
- Johnson & Johnson Innovation - JJDC
- Texas Medical Center
- VentureSouq
- MedTech Innovator
- Eight Capital
- Creative Destruction Lab
- Y Combinator
- JLabs
- Ariel Southeast Angel Partners
Competitors Overview
TYBR Health operates in the biomaterial therapies market, specifically focusing on products that protect tendons and ligaments during the healing process. Its main competitors include:
-
Artelon: This company specializes in improving ligament and tendon repair surgery with proprietary biomaterials that reinforce soft tissue. Their focus on soft tissue reinforcement provides a notable advantage in surgical outcomes.
-
Smith+Nephew: A well-established player in the orthopedic market, Smith+Nephew offers a range of products for tendon and ligament repair, including advanced surgical instruments and biomaterials. Their extensive experience and broad product range give them a competitive edge.
-
Zimmer Biomet: Known for its orthopedic solutions, Zimmer Biomet provides various products for soft tissue repair, including those targeting tendon and ligament injuries. Their strong market presence and comprehensive portfolio are significant advantages.
-
Xiros Ltd. (Neoligaments): This company focuses on innovative solutions for ligament repair, utilizing advanced biomaterials. Their specialization in ligaments offers a unique advantage in targeted therapies.
-
Cayenne Medical, Inc.: They provide arthroscopic surgery products, including systems designed for tendon repair. Their focus on sports medicine and minimally invasive techniques positions them well in the market.
These competitors differ in their specific focus areas, product offerings, and technological advancements, which can influence their market positioning relative to TYBR Health.
See something that needs updating? Suggest edits to this profile.